Proton-activated chloride channel 1 is essential for innate host defense against bacterial sepsis

L Lucien P. Garo (Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine) K Kevin Brueck (Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine) S Sarah Walachowski (Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine) A Archana Jayaraman (Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine) M Marcel Strueve (Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz) S Shuang Xu H Hulbert Yang (Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine) M Matthew Helmkamp (Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine) S Seung Hoan Choi (Broad Institute, Cambridge, MA, USA.) C Christoph Reinhardt (Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz) M Markus Bosmann (Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine)

Abstract

Bacterial sepsis remains a devastating clinical problem. Here, we describe a protective role for the recently discovered acid-sensitive, proton-activated chloride channel, PACC1 (PAC/ASOR/TMEM206), during sepsis. Initially, we found PACC1 was enriched in healthy human and mouse mononuclear phagocytes, particularly macrophages, and differentially regulated by inflammatory stimuli, suggesting PACC1 involvement in innate immunity. To further investigate, we generated de novo Pacc1 knockout ( −/− ) mice, which presented without major immunologic abnormalities at baseline. Compared to wild-type (WT), Pacc1 −/− myeloid cells showed normal phagocytic uptake of acid-insensitive Escherichia coli BioParticles , but impaired development of the acidifying phagolysosome using acid-sensitive E. coli BioParticles. Transcriptomic profiling of Pacc1 −/− macrophages revealed dysregulated phagolysosomal and cytokine networks (e.g., interferons). Because phagolysosomal bacterial clearance is essential to resolve infection, we challenged Pacc1 −/− mice with intraperitoneal gram-negative E. coli sepsis. Pacc1 −/− mice displayed increased bacterial burden, immune cell infiltration, inflammation, and lethality. In contrast, phagocytosis-independent E. coli lipopolysaccharide (LPS)-induced endotoxemia yielded comparable WT and Pacc1 −/− survival, as well as similar inflammatory responses. Finally, we engineered Pacc1 -floxed ( fl/fl ) mice crossed with a myeloid lineage Cre-deleter strain to interrogate myeloid cell–intrinsic PACC1 in vivo. Consistent with a predominate role for PACC1 during phagocytosis and bacterial clearance in these cells, LysM-Cre/Pacc1 fl/fl mice exhibited impaired E. coli sepsis survival but indifferent endotoxemia phenotypes. In conclusion, PACC1 links sterilizing phagolysosomal activity with immune networks in sepsis pathobiology.

Article Details

Volume / Issue Vol. 123, Issue 15
Published April 14, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (11)

L

Lucien P. Garo

Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine

K

Kevin Brueck

Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine

S

Sarah Walachowski

Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine

A

Archana Jayaraman

Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine

M

Marcel Strueve

Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz

S

Shuang Xu

H

Hulbert Yang

Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine

M

Matthew Helmkamp

Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine

S

Seung Hoan Choi

Broad Institute, Cambridge, MA, USA.

C

Christoph Reinhardt

Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz

M

Markus Bosmann

Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine